Emmerik Leijten

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Proteomics and metabolomicsTumour immunologyAutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 19, 2022
Multi-omics integration reveals a core network involved in host defence and hyperkeratinization in psoriasis.

Jingwen Deng, Emmerik Leijten, Michel Olde Nordkamp

|Oct 26, 2022
DNAM1 and TIGIT balance the T cell response, with low T cell TIGIT expression corresponding to inflammation in psoriatic disease.

Marleen E Jacobs, Juliëtte N Pouw, Michel A Olde Nordkamp

|Jan 16, 2021
Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis.

Emmerik F Leijten, Tessa S van Kempen, Michel A Olde Nordkamp

|Apr 19, 2018
Editorial: Lessons Learned From a "Failed" Clinical Trial.

E F A Leijten, T R D J Radstake, K A Reedquist

|Feb 21, 2017
Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?

Mark H Wenink, Emmerik F A Leijten, Tom Cupedo

Pageof 1